Nothing Special   »   [go: up one dir, main page]

ZA200606547B - Benzoxazine for treating respiratory tract diseases - Google Patents

Benzoxazine for treating respiratory tract diseases

Info

Publication number
ZA200606547B
ZA200606547B ZA200606547A ZA200606547A ZA200606547B ZA 200606547 B ZA200606547 B ZA 200606547B ZA 200606547 A ZA200606547 A ZA 200606547A ZA 200606547 A ZA200606547 A ZA 200606547A ZA 200606547 B ZA200606547 B ZA 200606547B
Authority
ZA
South Africa
Prior art keywords
benzoxazine
respiratory tract
treating respiratory
tract diseases
diseases
Prior art date
Application number
ZA200606547A
Other languages
English (en)
Inventor
Bouyssou Thierry
Pestel Sabine
Hoenke Christoph
Rudolf Klaus
Buettner Frank
Schollenberger Hermann
Konetzki Ingo
Schnapp Andreas
Lustenberger Philipp
Schromm Kurt
Heine Claudia
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA200606547B publication Critical patent/ZA200606547B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA200606547A 2004-04-22 2006-08-07 Benzoxazine for treating respiratory tract diseases ZA200606547B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004019539A DE102004019539A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittel zur Behandlung von Atemwegserkrankungen

Publications (1)

Publication Number Publication Date
ZA200606547B true ZA200606547B (en) 2008-04-30

Family

ID=34966948

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200606547A ZA200606547B (en) 2004-04-22 2006-08-07 Benzoxazine for treating respiratory tract diseases

Country Status (20)

Country Link
EP (1) EP1765355B1 (no)
JP (1) JP2007533684A (no)
KR (2) KR20130042662A (no)
CN (1) CN1946406A (no)
AU (1) AU2005235420C1 (no)
BR (1) BRPI0510084A (no)
CA (1) CA2559700C (no)
DE (1) DE102004019539A1 (no)
DK (1) DK1765355T3 (no)
EA (1) EA012045B1 (no)
EC (1) ECSP066948A (no)
ES (1) ES2403184T3 (no)
IL (1) IL177663A (no)
NO (1) NO20065061L (no)
NZ (1) NZ551272A (no)
PL (1) PL1765355T3 (no)
SG (1) SG152233A1 (no)
UA (1) UA85707C2 (no)
WO (1) WO2005102350A1 (no)
ZA (1) ZA200606547B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DK1917253T3 (da) 2005-08-15 2015-03-30 Boehringer Ingelheim Int Fremgangsmåde til fremstilling af betamimetika
EP1948186A1 (en) * 2005-11-09 2008-07-30 Boehringer Ingelheim International Gmbh Aerosolformulation for inhalation
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
CA2711637A1 (en) 2008-01-11 2009-07-16 Novartis Ag Pyrimidines as kinase inhibitors
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
EA201391230A1 (ru) 2011-02-25 2014-01-30 АйАрЭм ЭлЭлСи Соединения и композиции в качестве ингибиторов trk
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
EP3551187B1 (en) 2016-12-12 2021-02-17 Boehringer Ingelheim International GmbH Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
WO2024153813A1 (en) 2023-01-20 2024-07-25 Atrogi Ab Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
KR20020093083A (ko) * 2000-04-27 2002-12-12 베링거 잉겔하임 파르마 카게 신규한 완효성 베타모사체, 이의 제조방법 및 약제로서의이의 용도
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
BRPI0510084A (pt) 2007-10-16
WO2005102350A1 (de) 2005-11-03
AU2005235420A1 (en) 2005-11-03
AU2005235420C1 (en) 2011-02-24
EA200601837A1 (ru) 2007-04-27
CA2559700C (en) 2013-06-11
JP2007533684A (ja) 2007-11-22
CA2559700A1 (en) 2005-11-03
IL177663A (en) 2014-04-30
UA85707C2 (ru) 2009-02-25
NZ551272A (en) 2010-10-29
EP1765355A1 (de) 2007-03-28
DK1765355T3 (da) 2013-04-08
EA012045B1 (ru) 2009-08-28
ECSP066948A (es) 2006-12-20
AU2005235420B2 (en) 2010-10-28
KR20070054599A (ko) 2007-05-29
IL177663A0 (en) 2006-12-31
KR20130042662A (ko) 2013-04-26
ES2403184T3 (es) 2013-05-16
KR101338947B1 (ko) 2013-12-10
PL1765355T3 (pl) 2013-08-30
SG152233A1 (en) 2009-05-29
NO20065061L (no) 2006-11-07
CN1946406A (zh) 2007-04-11
EP1765355B1 (de) 2013-03-06
DE102004019539A1 (de) 2005-11-10

Similar Documents

Publication Publication Date Title
ZA200606547B (en) Benzoxazine for treating respiratory tract diseases
HUS1500058I1 (hu) Benzoxazint tartalmazó gyógyszer-kombináció légúti betegségek kezelésére
IL181049A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
GB0709512D0 (en) Disposable inhaler
EP1742641A4 (en) METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF RETINA DISEASES
IL178815A0 (en) The treatment of respiratory disease
IL190338A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
EP1962869A4 (en) TREATMENT OF RESPIRATORY DISEASES
IL180931A0 (en) Medicaments for treating chronic respiratory disease
PL1817282T3 (pl) Pochodne kwasu fenoksyoctowego użyteczne do leczenia chorób układu oddechowego
IL185444A0 (en) Novel drugs for treating respiratory diseases
GB0410399D0 (en) The treatment of respiratory disease
IL197125A0 (en) Drug combinations for treating airway diseases
GB0701456D0 (en) Treatment for respiratory disease
EP1755635A4 (en) TREATMENT OF INFLAMMATORY RESPIRATORY DISEASE
GB0403370D0 (en) Device for preventing retinal diseases
EP1731171A4 (en) PREVENTATIVE MEDICINE / REMEDY FOR RESPIRATORY DISEASES
ZA200606780B (en) Compounds for the treatment of diseases
EP1927353A4 (en) MEANS FOR THE TREATMENT OF CORNEAL DISEASES
GB0520152D0 (en) Treatment of respiratory disease
IL177531A0 (en) Compounds for the treatment of diseases
GB0420867D0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases
ZA200804944B (en) Use of a disinfectant for treating respiratory tract infections
AU303175S (en) Elbow for respiratory mask